News Agency
Men's Weekly

Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

  • Written by PR Newswire

MORRISVILLE, N.C., Jan. 9, 2023 /PRNewswire/ -- Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to conduct a Phase 1 multi-center study...

Read more: Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating...

How a Shopify Web Developer Can Make or Break Your eCommerce Store

Launching an online store today is easier than ever — but building one that actually performs well, drives traffic, and converts visitors into loyal customers is a different story. While Shopify offers a beginner-friendly interface, if you want to build... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion